Jon Napitupulu

Leios Therapeutics has licensed regional rights to 10XB-101, its minimally invasive injectable for focal fat reduction and body contouring,...

Enlivex Therapeutics has listed its primary treasury asset, the RAIN token, on WhiteBIT, effective January 21, 2026. WhiteBIT, the...

Adagene reported unaudited year-end cash of $74.5 million, guiding runway into late 2027, and outlined a dense slate of...

Ocular Therapeutix has appointed David W. Robinson as Global Chief Commercial Officer and granted him inducement equity awards effective...

INmune Bio outlined two near-term catalysts and a tighter clinical focus in an investor update: a mid‑summer 2026 UK...

Eurobio Scientific reported full-year 2025 revenue of €168 million, up 9% year over year, with comparable pro forma growth...

Agios Pharmaceuticals will report fourth quarter and full-year 2025 results on February 12, 2026 via webcast—an otherwise routine earnings...

BrightInsight has raised $13 million from Eclipse, General Catalyst, Insight Partners, Mayo Clinic, and New Leaf Venture Partners to...

60 Degrees Pharmaceuticals has partnered with Runway Health to expand pre-departure access to Arakoda (tafenoquine), the only once-weekly, broad-spectrum...

Invivyd has enlisted Olympic champion Lindsey Vonn for a national multimedia education campaign on antibodies and infectious disease prevention,...